Hindalco Mouda plant resumes operations for supply of aluminium foil packaging for COVID medicines

Hindalco has announced the reopening of aluminium foil plant in Mouda, near Nagpur, in response to requests from pharmaceutical packaging companies. The pharmaceutical companies are facing an acute shortage of specialised packaging material for Covid treatment drugs.

The aluminium foil manufactured in plant is being used for packing Chloroquine Phosphate tablets and Hydroxychloroquine sulphate tables and other critical drugs. Mouda facility, the largest producer of pharmaceutical foil in India, has been exempted from the nation-wide lockdown.

Mr. Anantha Bhat, Plant Head, Mouda, said, “The Mouda plant is committed to supporting the nation in its fight against COVID-19. We have re-started plant operations to meet the demand for packaging of critical drugs for COVID treatment. We are following the guidelines issued by governmental authorities, and are focused on prioritising employee health and safety, while fulfilling our duty to our country.”

Hindalco is following guidelines including operating with 50 per cent staff, ensuring social distancing, disinfection and sanitisation, distribution of masks and gloves, and screening and monitoring employees’ health and safety.

The company is also supplying aluminium for manufacture of medical equipment like ventilators, testing booths and transformers for make-shift hospitals set up for COVID patients. 

“Pharmaceutical companies like Cadilla, Cipla, Sun Pharma, Ipca and Lupin have placed orders with foil converters like Bilcare, ACG, Sanwariya, Baddi, Paras, Supermak. These foil-converting companies procure pharma foil from Hindalco and convert it into packaging material by printing, coating and laminating bare foil,” Hindalco said.